A Controlled Trial of Baclofen in Children with Cerebral Palsy

Journal of International Medical Research

Volumn 1, Issue 2, 1973, Pages 398-404

  Milla, P J ^a   Jackson, A D M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973765371     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006057300100203     Document Type: Article

References (16)

1. Ashworth B (1964) Preliminary trial of carisoprolol in multiple sclerosis. Practitioner 192, 540.
2. Bobath K Bobath B (1950) Treatment of spastic paralysis by the use of reflex inhibition. British Journal of Physical Medicine 13, 121.
3. Calta R G Traldi Sautomauro E (1976) The use of baclofen in children with cerebral palsy. Folha Med 73, (2). 199.
4. Cumming R (1972) Multiple sclerosis in the Shetlands with an evaluation of Lioresal. Postgraduate Medical Journal 48, (Oct. Suppl.). 34.
5. Curtis D R Watkins J C (1965) The pharmacology of aminoacids related to gamma-aminobutyric acid. Pharmacological Reviews 17, 347.
6. Davidoff R A (1972) Gamma-aminobutyric acid antagonism and presynaptic inhibition in the frog spinal cord. Science 175, 331.
7. Faigle J W Keberle H (1972) The chemistry and kinetics of Lioresal. Postgraduate Medical Journal 48, (Oct. Suppl.), 9.
8. Fehr H U Bein H J (1974) Sites of action of a new muscle relaxant (baclofen, Lioresal. CIBA 34, 647-Ba). Journal of International Medical Research 2, 36.
9. Hudgson P Weightman D (1971) Baclofen in the treatment of spasticity. British Medical Journal 4, 15.
10. Jones R F Burke D Marosszcky J E Gillies J D (1970) A new agent for the control of spasticity. Journal of Neurology, Neurosurgery and Psvchiatrv 33, 464.
11. Koella W P (1972) Pharmacological aspects of spasticity with special reference to Lioresal. Postgraduate Medical Journal 48, (Oct. Suppl.), 13.
12. Lancet (1970) Drug treatment of spasticity (Leader). Lancet 2, 918.
13. Lenman J A (1970) Use of drugs in the treatment of spasticity. Proceedings of the Royal Society of Medicine 63, 935.
14. Pedersen E (1969) Spasticity - mechanism, measurement, management. Thomas, Springfield, Illinois.
15. Pedersen E Arlien-Soberg P Grynderup V Henrikson D (1970) GABA derivative in spasticity ä-(4 chlorophenyl) aminobutyric acid, CIBA 34, 647-Ba. Acta Neurologica Scandinavica 46, 257.
16. Schwartzman J S Kogler E (1973) Pilot study of the effects of the product CIBA 34, 647 Ba in spastic cerebral paralysis. Fohla Medico 66, 1231.